Inappropriate Sinus Tachycardia Registry

Study Summary

The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.

Conditions

Inappropriate Sinus Tachycardia Postural Tachycardia Syndrome

Interventions / Drugs

AtriCure Commercially Available Devices

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment500 participants

Primary Completion—

Lead SponsorAtriCure, Inc.

Data Retrieved2026-04-11 02:55:07.545178+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.